2016 The Netherlands Business Trip

In order to promote Chengdu as a center for the healthcare field in China, Justgood Health Industry Group signed a strategic cooperation agreement with the Life Science Park of Limburg, Maastricht, the Netherlands on September 28th. Both sides agreed to set up offices to promote the bilateral industries of exchange and development.

This business trip was led by the director of Health and Family Planning Commission of Sichuan, Shen Ji. With 6 enterprises of the Chengdu Health Service Industry Chamber of Commerce.

The delegation group took a group photo with the head of the cardiovascular center of UMass in the Netherlands in the hospital, the partners have a high degree of mutual trust and high enthusiasm for cooperation projects.

The two-day visiting time is very tight, they have visited the UMass cardiovascular center operating room, the vascular department, and the project cooperation model, and the exchange of technical results to discuss. Huang Keli, director of cardiac surgery of Sichuan Provincial People’s Hospital, said that in the field of cardiovascular treatment, Sichuan discipline construction and hardware facilities are comparable to UMass, but in terms of hospital management system, UMass has a more perfect and efficient system, which can effectively shorten patient admission time and treat more patients with cardiovascular diseases, and UMass has filled the gap in the field of cardiovascular treatment through its technology and management, which is very worth Study.

The visit was very productive and impactful. The partners reached a consensus that they will make a focused and targeted landing with the actual situation in China, forming a medical service pattern with Sichuan as the core radiating China and Asia, making it a unique world-class medical center to improve the level of medical treatment in China. In order to improve the level of treatment of cardiovascular diseases in China, the high prevalence of cardiovascular diseases will be effectively prevented and controlled for the benefit of patients who are plagued by cardiovascular diseases.